Home
HelpTest Code FUFXS Fragile X, Follow-up Analysis
Reporting Name
Fragile X, Follow up AnalysisPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Confirming the methylation status of the repeat expansion allele in the FMR1 gene, to aid the diagnosis of FMR1-related disorders
Method Name
Only orderable as a reflex. For more information see FXS / Fragile X Syndrome, Molecular Analysis, Varies.
Methylation Sensitive Polymerase Chain Reaction (PCR) Fragment Analysis
Specimen Required
Only orderable as a reflex. For more information see FXS / Fragile X Syndrome, Molecular Analysis, Varies.
No additional specimen is required. Lab will utilize specimen they already have in the lab for this test.
Specimen Type
VariesSpecimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Varies | ||
Reference Values
Only orderable as a reflex. For more information see FXS / Fragile X Syndrome, Molecular Analysis, Varies.
Interpretation
An interpretive report will be provided.
Day(s) Performed
Monday, Wednesday
Report Available
8 to 10 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81244
LOINC Code Information
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 52421 | Comment | 48767-8 |
| 52422 | Specimen | 31208-2 |
| 52423 | Source | 31208-2 |
| 52424 | Released By | 18771-6 |